Effects of Levosimendan on Endothelial Function and Hemodynamics During Weaning From Veno-Arterial Extracorporeal Life Support-Reference-Cited by-同舟云学术

Effects of Levosimendan on Endothelial Function and Hemodynamics During Weaning From Veno-Arterial Extracorporeal Life Support

Published:2016-12 Issue:6 Volume:30 Page:1449-1453
ISSN:1053-0770
Container-title:Journal of Cardiothoracic and Vascular Anesthesia
language:en
Short-container-title:Journal of Cardiothoracic and Vascular Anesthesia

Author:

Sangalli Fabio,Avalli Leonello,Laratta Matteo,Formica Francesco,Maggioni Elena,Caruso Rosa,Cristina Costa Maria,Guazzi Marco,Fumagalli Roberto

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Coppo A, Galbiati L, Redaelli G: Weaning from extracorporeal circulatory support. In: Sangalli F, et al, eds. ECMO-extracorporeal Life Support in Adults. Milan, Italy: Springer-Verlag Italia; 2014:207-215

2. How to wean a patient from veno-arterial extracorporeal membrane oxygenation;Aissaoui;Intensive Care Med,2015

3. Pharmacologic approaches to weaning from cardiopulmonary bypass and extracorporeal membrane oxygenation. Best Practice and Research Clinical;Cui;Anesthesiology,2015

4. Timing and strategy for weaning from venoarterial ECMO are complex issues;Pappalardo;J Cardiothorac Vasc Anesth,2015

5. Levosimendan may improve weaning outcomes in venoarterial ECMO patients;Affronti;ASAIO J,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis;Clinical Research in Cardiology;2023-05-22

2. Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data;Critical Care;2023-02-07

3. Initial Management of Transported Patients After Arrival on ICU;ECMO Retrieval Program Foundation;2023

4. Levosimendan: mechanistic insight and its diverse future aspects in cardiac care;Acta Cardiologica;2022-10-12

5. Levosimendan reverses the cardiac malfunction and cardiomyocyte ferroptosis under heart failure with preserved ejection via connexin43 signaling activation;2022-09-06